# Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

> **NCT00866021** · PHASE4 · COMPLETED · sponsor: **Fundacion SEIMC-GESIDA** · enrollment: 68 (actual)

## Conditions studied

- HIV/HCV Co-infection
- HIV Infections

## Interventions

- **DRUG:** Lopinavir/ritonavir
- **DRUG:** Lopinavir/ritonavir with two nucleoside analogs

## Key facts

- **NCT ID:** NCT00866021
- **Lead sponsor:** Fundacion SEIMC-GESIDA
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2012-06
- **Final completion:** 2012-10
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2025-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00866021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00866021, "Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00866021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*